Who invested in C2i Genomics?
C2i Genomics's investors include NFX, Casdin Capital and S32.
Who invested in C2i Genomics
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $100MApr 2021
- Investors
- 3
The rounds
- Apr 2021
Founders and team
From C2i Genomics's own website and the SEC filings it signed: 8 on the team.
- Marc StapleyChief Executive Officer
- Jonathan WygantChief Accounting Officer
- Rebecca ChambersChief Financial Officer
- Steven FrenchChief Information Officer
- Tracy WardChief Human Resources Officer
- Annie McGuireGeneral Counsel & Head of Market Access
- Asaf ZviranExecutive Officer, Directori
- Ezra SoferExecutive Officer, Directori
On the board, as filediAlex ParkerEli CasdinShaun Rodriguez
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists C2i Genomics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about C2i Genomics
How much has C2i Genomics raised?
C2i Genomics has raised $100M across 1 round since 2021.
When did C2i Genomics last raise?
C2i Genomics's most recent round was a Series B of $100M in Apr 2021.
What was C2i Genomics's biggest round?
Its most recent round, $100M in Apr 2021, is also its largest on record.
Who backed C2i Genomics first?
C2i Genomics's first round on record, in Apr 2021, was backed by NFX, Casdin Capital and S32.
What stage is C2i Genomics at?
C2i Genomics's latest named round is a Series B, in Apr 2021.
Companies like C2i Genomics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.